SCHEMBL1285014

SCHEMBL1285014

CCOCc1cc2ccccc2oc1=Nc1ccc(OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 8/20 0.45
AKR1B1 P15121 8/20 0.45
KMT2A Q03164 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 8/20 0.43
TDP1 Q9NUW8 4/20 0.43
LMNA P02545 3/20 0.43
MAPK1 P28482 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
KDM4E B2RXH2 2/20 0.41
AKR1A1 P14550 1/20 0.41
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1285011 1.00 AKR1B10 (0.45) AKR1B10AKR1B1KMT2ANPC1RAB9A
SCHEMBL1284937 0.89 AGXT (0.40) AKR1B10AKR1B1KMT2ANPC1RAB9A
SCHEMBL1284938 0.89 AGXT (0.40) AKR1B10AKR1B1KMT2ANPC1RAB9A
SCHEMBL1284729 0.88 MAPT (0.53) KMT2ANPC1RAB9AMAPTMAPK1
SCHEMBL1284730 0.88 MAPT (0.53) KMT2ANPC1RAB9AMAPTMAPK1
SCHEMBL1284893 0.87 NPC1 (0.57) AKR1B10AKR1B1KMT2ANPC1RAB9A
SCHEMBL1284891 0.87 NPC1 (0.57) AKR1B10AKR1B1KMT2ANPC1RAB9A
SCHEMBL1285467 0.87 MAPT (0.40) AKR1B10AKR1B1KMT2ARAB9AMAPT
SCHEMBL1284660 0.87 MAOB (0.40) AKR1B10AKR1B1KMT2AKDM4EMEN1
SCHEMBL1285390 0.87 CA12 (0.39) AKR1B10AKR1B1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 AKR1B10 118/4885AKR1B1 188/4885KMT2A 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.